Wall Street brokerages forecast that Vir Biotechnology, Inc. (NASDAQ:VIR) will announce $2.65 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Vir Biotechnology’s earnings, with the highest sales estimate coming in at $2.80 million and the lowest estimate coming in at $2.50 million. Vir Biotechnology reported sales of $980,000.00 […]